Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
BOSTON and ATLANTA, Nov. 14, 2023 (GLOBE NEWSWIRE) Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course
Jane Frances Holmes, age 72, passed away peacefully on Nov. 2, 2023, at the Pheasant Wood Center in Peterborough, surrounded by the support and love of her family and friends.
– ATH434-201 is a randomized, double-blind, placebo-controlled study in early-stage MSA – – Lead clinical development program enrolled 77 participants.